YL
Yang Li
Chief Technology OfficerDr. Yang Li, Ph.D., serves as Chief Technology Officer at Clover Biopharmaceuticals, Ltd. since 2023 and had been its Senior Vice President of Process Development and Manufacturing Science (PDMS) since December 2021 until 2023 with experience in biologic therapeutics process and product development. Prior to Clover, Dr. Li was the VP, CMC Head of Overland Pharma Shanghai China. Prior to that, Dr. Li assumed VP/CMC head, Senior Scientist, and Scientist positions at Lyvgen Biopharma, Celgene Corporation, and Bristol-Myers Squibb, respectively. Dr. Yang Li obtained his Ph.D degree in Bioengineering from Massachusetts Institute of Technology.
Positions
- Company NameClover Biopharmaceuticals, Ltd.Stock Code02197PositionChief Technology OfficerColleagues
- PLPeng LiangFounder, Chief Scientific Officer & Chairman of the Board
- JGJoshua G. LiangCEO & Executive Director
- HHHtay Htay HanChief Medical Officer of Vaccine
- BMBerry MichaelChief Technical Operation Officer
- XWXiaobin WuIndependent Non-Executive Director
- TEThomas Edward LeggettIndependent Non-Executive Director
- XWXiaodong WangNon-Executive Director
